Formicamycin biosynthesis involves a unique reductive ring contraction

Zhiwei Qin, Rebecca Devine, Thomas Booth, Elliot Farrar, Matthew Grayson, Matt Hutchings, Barrie Wilkinson

Research output: Contribution to journalArticlepeer-review

11 Citations (Scopus)
25 Downloads (Pure)


Fasamycin natural products are biosynthetic precursors of the formicamycins. Both groups of compounds are polyketide natural products that exhibit potent antibacterial activity despite displaying different three-dimensional topologies. We show here that transformation of fasamycin into formicamycin metabolites requires two gene products and occurs via a novel two-step ring expansion-ring contraction pathway. Deletion of forX, encoding a flavin dependent monooxygenase, abolished formicamycin production and leads to accumulation of fasamycin E. Deletion of the adjacent gene forY, encoding a flavin dependent oxidoreductase, also abolished formicamycin biosynthesis and led to the accumulation of new lactone metabolites that represent Baeyer-Villiger oxidation products of the fasamycins. These results identify ForX as a Baeyer-Villiger monooxygenase capable of dearomatizing ring C of the fasamycins. Through in vivo cross feeding and biomimetic semi-synthesis experiments we showed that these lactone products represent biosynthetic intermediates that are reduced to formicamycins in a unique reductive ring contraction reaction catalyzed by ForY.
Original languageEnglish
Pages (from-to)8125-8131
Number of pages7
JournalChemical Science
Issue number31
Early online date16 Jun 2020
Publication statusPublished - 21 Aug 2020

Cite this